ProMIS Neurosciences Inc. (T:PMN*CA)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEDI filings (by transaction date) for PMN*CA within the last 6 months
[?]
Amended Filing
As of 11:59pm ET June 5th, 2023
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 19/22 Dec 16/22 Williams, Eugene Warren Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $4.64
USD
Dec 19/22 Dec 16/22 Williams, Eugene Warren Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $4.65
USD
Dec 15/22 Dec 15/22 Kirwin, Patrick D. Indirect Ownership Common Shares 10 - Acquisition in the public market 2,000 $6.16
Dec 16/22 Dec 14/22 Farfel, Gail Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $4.94
USD
Dec 15/22 Dec 13/22 Kirwin, Patrick D. Indirect Ownership Common Shares 10 - Acquisition in the public market 1,000 $6.60
Dec 13/22 Dec 12/22 Williams, Eugene Warren Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $5.08
USD
Dec 13/22 Dec 9/22 Kirwin, Patrick D. Indirect Ownership Common Shares 10 - Acquisition in the public market 1,000 $6.80
Dec 10/22 Dec 7/22 Williams, Eugene Warren Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $5.49
USD
Dec 10/22 Dec 6/22 Farfel, Gail Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $5.70
USD
Dec 7/22 Dec 2/22 Williams, Eugene Warren Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $5.98
USD
Sign up or login above to see all SEDI filings within the past 6 months.
Latest 10 SEDI filings (by filing date) for PMN*CA within the last 6 months
[?]
Amended Filing
As of 11:59pm ET June 5th, 2023
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 19/22 Dec 16/22 Williams, Eugene Warren Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $4.64
USD
Dec 19/22 Dec 16/22 Williams, Eugene Warren Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $4.65
USD
Dec 16/22 Dec 14/22 Farfel, Gail Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $4.94
USD
Dec 15/22 Dec 15/22 Kirwin, Patrick D. Indirect Ownership Common Shares 10 - Acquisition in the public market 2,000 $6.16
Dec 15/22 Dec 13/22 Kirwin, Patrick D. Indirect Ownership Common Shares 10 - Acquisition in the public market 1,000 $6.60
Dec 13/22 Dec 12/22 Williams, Eugene Warren Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $5.08
USD
Dec 13/22 Dec 9/22 Kirwin, Patrick D. Indirect Ownership Common Shares 10 - Acquisition in the public market 1,000 $6.80
Dec 10/22 Dec 6/22 Farfel, Gail Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $5.70
USD
Dec 10/22 Sep 19/22 Farfel, Gail Direct Ownership Common Shares 00 - Opening Balance-Initial SEDI Report    
Dec 10/22 Dec 7/22 Williams, Eugene Warren Direct Ownership Common Shares 10 - Acquisition in the public market 1,000 $5.49
USD
Sign up or login above to see all SEDI filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider.
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $PMN.CA

  • No tweets found

Competitors

Competitors with Recent Insider Filings
BELLUS Health (T:BLU*CA)
FSD Pharma (C:HUGE*CA)
BriaCell Therapeutics (T:BCT*CA)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.